Bristol Myers Squibb (NYSE: BMY)
Bristol Myers Squibb Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bristol Myers Squibb Company Info
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
News & Analysis
Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?
Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?
2 High-Yield Dividend Stocks Billionaires Are Buying Hand Over Fist
These reliable dividend payers offer yields of 3.3% and better at recent prices.
Is Bristol Myers Squibb Stock a Buy?
The company is going through a rough patch.
Is Bristol Myers Squibb Stock a Buy Now?
This healthcare stock has seen healthier days.
Better Dividend Stock: Bristol Myers Squibb or Merck?
These two pharma stocks have sizable dividend yields. Which is the better buy right now?
Is Bristol Myers Squibb Stock a Buy Now?
The answer might depend on the kind of investor you are.
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
Regulators are already on the case, and their findings will have financial impacts.
Why Bristol Myers Squibb Stock Is Fading Today
A high-profile clinical failure by a rival is weighing on the drugmaker's shares today.
Valuation
Podcast Episodes
The Top Biotech Stocks to Watch Following ASH 2019
The potential to reshape treatment of blood cancer and disorders could mean big bucks for these companies.
3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year
These stocks skyrocketed following exciting announcements.
Carl Icahn Takes Aim at Bristol-Myers Squibb
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
In this Valentine's Day edition, Industry Focus explores cholesterol busters, heart surgery, and the latest in anticoagulants.
Earnings Transcripts
Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript
BMY earnings call for the period ending December 31, 2023.
Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2023.
Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript
BMY earnings call for the period ending June 30, 2023.
Bristol-Myers Squibb (BMY) Q4 2022 Earnings Call Transcript
BMY earnings call for the period ending December 31, 2022.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.